In the present study, we compared the kinetics of TRAIL-mediated decrease of surface DR4 and DR5 receptors expression in TRAIL-resistant (HT-29, A549) and TRAIL-sensitive (HCT116, Jurkat) tumor cell lines. The gene discussed is TNFRSF10A; the disease is neoplasm.